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Abstract
Migration of naı¨ve and activated lymphocytes is regulated by the expression of various molecules such as chemokine
receptors and ligands. CD69, the early activation marker of C-type lectin domain family, is also shown to regulate the
lymphocyte migration by affecting their egress from the thymus and secondary lymphoid organs. Here, we aimed to
investigate the role of CD69 in accumulation of CD4 T cells in intestine using murine models of inflammatory bowel disease.
We found that genetic deletion of CD69 in mice increases the expression of the chemokines CCL-1, CXCL-10 and CCL-19 in
CD4+ T cells and/or CD42 cells. Efficient in vitro migration of CD69-deficient CD4 T cells toward the chemokine stimuli was
the result of increased expression and/or affinity of chemokine receptors. In vivo CD692/2 CD4 T cells accumulate in the
intestine in higher numbers than B6 CD4 T cells as observed in competitive homing assay, dextran sodium sulphate (DSS)-
induced colitis and antigen-specific transfer colitis. In DSS colitis CD692/2 CD4 T cell accumulation in colonic lamina propria
(cLP) was associated with increased expression of CCL-1, CXCL-10 and CCL-19 genes. Furthermore, treatment of DSS-
administrated CD692/2 mice with the mixture of CCL-1, CXCL-10 and CCL-19 neutralizing Abs significantly decreased the
histopathological signs of colitis. Transfer of OT-II6CD692/2 CD45RBhigh CD4 T cells into RAG2/2 hosts induced CD4 T cell
accumulation in cLP. This study showed CD69 as negative regulator of inflammatory responses in intestine as it decreases
the expression of chemotactic receptors and ligands and reduces the accumulation of CD4 T cells in cLP during colitis.
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Introduction
In the intestinal immune system chemokine ligands and
receptors regulate the migration of lymphocytes. Naı¨ve cells
express high levels of L-selectin (CD62L) and chemokine receptor
CCR-7 that recognize secondary lymphoid organs (SLO)-
expressed addressin and the chemokines CCL-19 and CCL-21,
respectively [1,2,3]. Lymphocyte egress from the SLO depends on
the expression of sphingosine 1-phosphate receptor type 1 (S1P1)
on the lymphocyte surface and its interaction with the ligand
sphingosine 1-phosphate (S1P) that is abundant in the lymph [4,5].
Activated lymphocytes express different combinations of chemo-
kine receptors depending on their migration destination and the
subtype they differentiate to. For example Th1 cells express
CXCR-3 (binding CXCL-10) [6], Th17 cells express CCR-6
(binding CCL-20) [7] while CCR-8 (binding CCL-1) is implicated
in Th2 responses but studies showed its expression primarily on
the memory cells of Th2 subtype and Foxp3 regulatory (Treg) cells
[8]. Lymphocytes that migrate from the SLO to the gut express
the chemokine receptor CCR-9 and the integrin a4b7 that bind
CCL-25 and mucosal addressin cell adhesion mlecule-1 (Mad-
CAM-1), respectively [1,2].
Inflammatory bowel disease (IBD), such as Crohn’s disease (CD)
and ulcerative colitis (UC) are thought to be the product of a
deregulated immune response to constituents of the intestinal
microflora. The migration of lymphocytes to the lamina propria
seems to be a key event for the pathogenesis of IBD. Strategies that
block the recruitment of leukocytes into the intestine represent a
potentially potent treatment of IBD. The anti-a4 mAb was
efficient in the treatment of CD [9] but it increases the
susceptibility to any infection showing the need for tissue specific
migration inhibitor. FTY-720 (fingolimid) as the agonist of S1P
receptor family was very effective in the animal models of IBD
[10,11], but it showed the side effect of bradycardia in the clinical
trials [12] due to expression of S1P3 receptor on myocard [13].
Studies are now being conducted with the agonists specific only for
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S1P1 receptor expressed exclusively on lymphocytes [13] and some
of them are promising in the IBD treatment [14,15]. Also the mAb
to CXCL-10 as the agent that specifically inhibit the migration of
Th1 cell subset, is in the clinical trials for the treatment of UC [9].
The C-type lectin receptor CD69 (encoded in NK gene cluster)
is the earliest activation antigen of lymphocytes. This molecule is
shown to be involved in the regulation of immune responses in
murine models of asthma [16,17], arthritis [18,19], colitis [20],
myocarditis [21], pathogen clearance [22] and tumors [23,24].
CD69 activation induces TGF-b expression and suppresses the
production of pro-inflammatory cytokines IL-17 and IFN-c
[19,20,23,25,26]. Studies showed that activation of CD69 leads
to ERK phosphorylation and thus stabilizes TGF-b on the cell
surface of lymphocytes [27]. After allogenic bone-marrow
transplantation CD4+CD69+CD252 T cells protect from the
development of graft-versus host disease [28]. CD69+ T cells are
able to induce indoleamine 2,3-dioxygenase (IDO) in tumor-
associated macrophages and hence down-regulate inflammatory
immune responses [29]. Therefore CD4+CD69+CD252 T cells
have been introduced as novel regulatory cell type whose effector
functions depend mainly on TGF-b.
Besides regulating the cytokine response, CD69 has also been
shown to affect the migration of immune cells. Constitutive
overexpression of CD69 in transgenic animals implicated a role of
this molecule in releases of lymphocytes from the thymus [30,31].
Furthermore, CD69 directly interact with S1P1 receptor on the
lymphocyte surface inducing the down-regulation of S1P1
expression [32,33]. Consequently, CD69 mediates the retention
of activated lymphocytes in the SLO [4,32]. The migration of
dendritic cells (DC) from the skin to draining lymph nodes is
increased in CD69-deficient animals [34]. Overall, these studies
suggested an important role of CD69 in regulating the migration
of lymphocytes, but the molecular mechanism of this effect is not
completely solved.
This study showed that CD69-deficiency increases CCL-1,
CXCL-10 and CCL-19 expression. CD69-defiecient CD4 T cells
migrated rapidly toward the chemokine gradient in vitro and
accumulated in the intestinal tissues in vivo. Furthermore, CD692/
2 animals showed increased fraction of naı¨ve and decreased
fraction of memory CD4 T cells compared to B6 animals. Absence
of CD69 induced severe intestinal inflammation in DSS-induced
colitis and antigen-specific transfer colitis. Severity of the colitis
could be ameliorated in DSS-administrated CD69-deficeint mice
with the neutralization of CCL-1, CXCL-10 and CCL-19. These
data indicated that CD69 is an important regulator of immune
responses that regulates the expression of chemokines and cell
accumulation during intestinal inflammation.
Materials and Methods
Mice
Inbred C57BL/6J (B6) mice, RAG2/2 (RAGtm1Mom), CD692/
2 mice [17,18,20], B6.Cg-Tg (CAG-DsRed*MST) 1 Nagy/J (in
text referred as DsRed mice) [35], T cell receptor (TCR)-
transgenic OT-II, OT-II6CD692/2 [20] and OT-II6DsRed all
on CD45.2 background, as well as B6 mice on CD45.1
background (B6.SJL-Ptprca Pep3b/BoyJ ) [36] were bred and kept
under specific pathogen-free (SPF) conditions in the animal facility
of Ulm University (Ulm, Germany). Female and male mice were
used at 6–12 weeks of age. The local animal committee
(Regierungspra¨sidium Tu¨bingen) approved the animal protocols
(protocol no. #1010, #1067 and #1089). All animal experiments
were performed according to the guidelines of the local Animal
Use and Care Committee and the National Animal Welfare Law.
Dextran Sodium Sulphate (DSS)-induced Colitis
B6 and CD692/2 mice were fed 2% DSS salt (cat. no. 160110;
MP Biomedicals, Illkirch, France) dissolved in sterile water ad
libitum for five days. On day 5, DSS containing water was
removed and replaced with normal sterile water. In one
experiment mice were treated with chemokine antagonists (anti-
CCL-1 Ab 148113 (cat. no. MAB845), anti-CXCL-10 Ab 134013
(cat. no. MAB466) and anti-CCL-19 Ab 87201 (cat no. MAB880)
all purchased from R&D Systems, Wiesbaden, Germany). The
mixture of the respective anti-chemokine Abs was injected i.p. on
days 0, 2, 4 and 6 after DSS administration with the concentration
of the individual Ab being 1 mg/kg. The weight of mice and their
clinical condition were monitored daily. Mice were sacrificed at
day 3 or at the peak of disease, at day 7 after DSS administration.
Tissue samples for histopathological examination were taken from
the large intestine, fixed in neutral-buffered formalin, embedded in
paraffin, sectioned on a microtome, mounted on slides, and
stained with hematoxylin and eosin (H&E). Histology of the large
intestine was categorized as normal (score 0); mild colitis (score 1),
with few inflammatory cells in the lamina propria (LP),
stromaedema, and a slight reduction of goblet cells; moderate
colitis (score 2), with an intense inflammatory infiltration of the LP,
hyperplasia of crypts, and a marked reduction of goblet cells; or
severe colitis (score 3), with a spillover of leukocytes beyond the
mucosa into deeper layers of the colonic wall, complete loss of
goblet cells, distortion of the mucosal architecture, erosions or
ulcerations, and crypt abscesses as previously published [20,37,38].
Antigen-specific Transfer Colitis Model
Total spleen cells of OT-II or OT-II6CD692/2 mice were
isolated and stained for CD4 and CD45RB with FITC-
conjugated mAb binding CD4 GK1.5 (cat. no. 11-0041-86;
eBioscience, Frankfurt, Germany) and biotinylated mAb binding
CD45RB 16A (cat. no 553093; BD Biosciences, Heidelberg,
Germany), followed by the second-step reagent Streptavidin-
Peridinin Chlorophyll Protein (PerCP)-Cy5.5 (cat. no. 45-4317-
80; eBioscience). CD45RBhigh T cells from the CD4+ population
were enriched using the FACSAria system (BD Biosciences) to a
purity .95%. Purified CD45RBhigh CD4 T cells were injected i.p.
into RAG2/2 mice (36105 cells/mouse). Hosts were fed or not
intragastrically every second day with 1 mg of chicken ovalbumin
(OVA) protein (cat. no. A5253; grade II, Sigma-Aldrich,
Steinheim, Germany) dissolved in 100 ml of PBS. The weight of
transplanted mice and their clinical condition were monitored
twice weekly. Tissue samples for histopathological examination
were taken from the large intestine, fixed in neutral-buffered
formalin, embedded in paraffin, sectioned on a microtome,
mounted on slides, and stained with H&E. Histological scoring
was preformed same as described above for the DSS colitis model.
In vitro Chemokine Receptor Functionality Assay
Chemokine stocks were made in PBS supplemented with 0.1%
of BSA and diluted in RPMI medium containing 10% FBS and
1% Penicillin/Streptomycin when used for experiments. Concen-
trations of CCL-1 (cat. no. 845-TC; R&D Systems), CXCL-10
(cat. no. 466-CR; R&D Systems), CCL-5 (cat. no. 478-MR; R&D
Systems) and CCL-4 (cat. no. 451-MB; R&D Systems) were
titrated (from 0.5 nM to 200 nM) and 600 ml of only medium or
medium containing chemokine was added in the lower chamber of
24-well transwell system with 5 mm pore size polycarbonate
membrane (cat. no. 3421; Corning, New York). This membrane
does not allow the medium to diffuse, but allows T cells to migrate
from one chamber to another. After loading the lower chamber,
inserts containing the membrane were carefully placed into the
The Role of CD69 in CD4 T Cell Migration
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e65413
wells. CD4 T cells were enriched from the total spleen cells of B6
and CD692/2 mice using the MACS CD4 T cell isolation kit (cat.
no. 130-090-860; Miltenyi Biotec, Bergisch Gladbach, Germany).
46105 B6 or CD692/2 CD4 T cells in 100 ml of RPMI, 10%
FBS, 1% Penicillin/Streptomycin medium were added to the
upper chambers. Plate was covered and incubated 1 hour at 37uC,
5% CO2. Transwell inserts were carefully removed and cells in the
lower chamber media counted by FACSCalibur. All reactions
were done in at least four repeats. The chemotactic index was
calculated as: the number of cells migrating to the media with
chemokine divided by the average number of cells migrating to the
media alone as previously described [39].
In vivo Competitive Homing Assay
CD4 T cells were enriched via MACS CD4 T cell isolation kit
from the spleens of DsRed or CD692/2 mice (both on B6
CD45.2+ background). CD692/2 CD4 T cells were labelled with
cell trace dye carboxyfluorescin succinimidyl ester (CFSE, cat. no.
C34554; Invitrogen, Darmstadt, Germany): 107 cells were washed
two times with PBS, resuspended in 1 ml of PBS, 0.1% BSA and
than incubated 15 min on 37uC, 5% CO2 with 5 mM final
concentration of CFSE diluted in DMSO; labelling reaction was
stopped by adding 1 ml of cold FBS and washing the cells two
times with PBS. DsRed B6 and CSFE+ CD692/2 CD4 T cells
were mixed in a 1:1 ratio and resuspended in PBS. 106 of each cell
population in 200 ml of PBS were i.v. transferred to CD45.1+ B6
mice. Small amount of cells was saved after injection for
calculating input ratio (IR). These cells were extracellulary stained
for CD4 with APC-conjugated mAb binding CD4 GK1.5 (cat.
no. 17-0041-83; eBioscience) and for CD45.2 with biotinylated
anti-CD45.2 mAb 104 (cat. no. 553771; BD Bioscience) and
PerCP-Cy5.5 as a second-step reagent. Cells were analyzed by
Flow Cytometry (FCM) and IR was calculated as:
IR=number of CD4+CD45.2+CFSE+ cells/number of
CD4+CD45.2+DsRed+ cells.
Transferred hosts were euthanized 18 or 72 h after injection.
Cells were isolated from the mesenteric lymph nodes (MLN),
blood, small intestinal lamina propria (siLP) and colonic lamina
propria (cLP) of the hosts and stained same as the sample before
injection (with APC-conjugated mAb binding CD4 GK1.5,
biotinylated mAb binding CD45.2 104 and PerCP-Cy5.5 as a
second-step reagent). Samples were analyzed by FCM and homing
index (HI) for every tissue calculated as:
HI =number of CD4+CD45.2+CFSE+ cells/number of
CD4+CD45.2+DsRed+ cells : IR.
As suggested [39] this index was normalized to the HI in the
blood to eliminate possible retention of the one cell type in some of
the secondary lymphoid tissues which could eliminate that cell
type from the circulation.
In a separate experiment 16107 of each cell population in
200 ml PBS were i.v. injected to one B6 mouse. 18 h post-injection
small intestine and colon were isolated and washed from faeces
with PBS/1% FBS using tubing needle. Washed small intestine
and colon were incubated for 1 h at room temperature in dark
with Alexa Fluor 350-conjugated Wheat Germ Agglutinin (WGA,
cat. no. W11263; Invitrogen), 20 mg/ml final concentration, in
1 ml PBS/1%FBS. WGA binds mucus glycoproteins in the
intestine [40] staining for the surface of intestinal epithelium.
Small intestinal and colonic tissues were analyzed by LSM 710
Confocal Laser Scanning Microscope (Zeis, Jena, Germany) and
different fluorescent colours were detected using following
excitation/emission spectra: for Alexa Fluor 350 350 nm/408–
464 nm, for DsRed 512 nm/591–715 nm and for CFSE 488 nm/
493–525 nm. Pictures were obtained at the original magnification
40x/1.30 oil DIC M27 and were analyzed using LSM Image
Browser software (Zeis, Jena, Germany).
Antigen-specific in vivo Competitive Homing Assay
CD4 T cells from the spleen of OT-II6DsRed or OT-
II6CD692/2 mice (both on Vb5+ background) were enriched
by MACS and OT-II6CD692/2 CD4 T cells were labelled with
CFSE by the protocol described in previous section. OT-
II6DsRed and CSFE+ OT-II6CD692/2 CD4 T cells were
mixed in a 1:1 ratio and 106 of each cell population in 200 ml of
PBS were i.v. transferred to B6 hosts. A small amount of cells was
saved after injection for calculating IR. These cells were
extracellulary stained for CD4 with APC-conjugated mAb binding
CD4 GK1.5 and for Vb5 with biotinylated anti- Vb5.1, 5.2 mAb
MR9-4 (cat. no. 553188; BD Bioscience) and PerCP-Cy5.5 as a
second-step reagent. Cells were analyzed by FCM and IR was
calculated as:
IR=number of CD4+ Vb5+CFSE+ cells/number of CD4+
Vb5+DsRed+ cells.
Hosts were fed or not intragastrically with 1 mg OVA protein in
100 ml PBS daily. 72 h after injection hosts were euthanized and
cells from the MLN, blood, siLP and cLP were isolated and
stained same as the IR sample (with APC-conjugated mAb
binding CD4 GK1.5, biotinylated mAb binding Vb5.1, 5.2 MR9-
4 and PerCP-Cy5.5 as a second-step reagent). Cells were analyzed
by FCM and HI for every tissue calculated as:
HI= number of CD4+ Vb5+CFSE+ cells/number of CD4+
Vb5+DsRed+ cells : IR.
As before, this HI was normalized to the HI of the blood.
Microarray Data
Gene expression data of B6, CD69-activated B6 and CD692/2
CD4 T cells have analyzed as previously described by our group
[20]. These data are accessible at NCBI GEO database (GEO;
accession number GSE27706).
CD4 T cell Isolation
CD4 T cells were isolated from the blood, cLP, siLP, spleen and
MLN of B6, CD692/2, DsRed, OT-II, OT-II6CD692/2, OT-
II6DsRed and CD45.1 B6 mice.
Isolation of blood cells. Arterial blood was obtained from
the mice, mixed with EDTA as anti-coagulant and red blood cells
were lysed by 3 times 5 min incubation on 37uC with 5 ml of
Lysebuffer (0.16 M NH4Cl and 0.17 M Tris, pH 7.2) followed by
washing with PBS/1%FBS.
Isolation of spleen and MLN cells. Single-cell suspensions
were aseptically prepared from spleen and MLN and red blood
cells from spleen were lysed by 10 min incubation on 37uC with
5 ml of Lysebuffer. All the cells were washed and resuspended in
PBS supplemented with 1% FBS.
Isolation of small intestinal and colonic lamina propria
cells. Segments of the small intestine or colon were washed with
PBS to remove debris and mucous. The epithelium was removed
by incubation at 37uC for 10–15 min under gentle shaking with
1 mM dithiothreitol (and 1 mM EDTA for colon tissue) in 25 ml
PBS supplemented with 1% FBS. The remaining tissue was
washed in PBS to remove residual epithelial cells, and the
supernatants were discarded. Intestinal tissues were cut into 262-
mm pieces and digested by incubation with 0.25 mg/ml collage-
nase type VIII from Clostridium histolyticum (cat. no. C-2139;
Sigma-Aldrich, St. Louis, MO) for 30–45 min at 37uC in RPMI
1640 under shaking. Supernatants were collected, from which LP
lymphocytes were pelleted. LP lymphocytes were resuspended in
RPMI 1640 medium containing 35% Percoll (density 1.124 g/ml;
The Role of CD69 in CD4 T Cell Migration
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cat. no. L-6145; Biochrome, Berlin, Germany). This cell suspen-
sion was overlaid onto 70% Percoll and centrifuged for 20 min at
7506g. Viable cells at the 35%/70% Percoll interface were
collected and washed twice.
Extracellular Staining
Cells were washed twice in PBS supplemented with 0.3% BSA
and 0.1% sodium azide. Non-specific binding of antibodies to Fc
receptors was blocked by preincubation of cells with mAb 2.4G2
(cat. no. 01241D; BD Biosciences) directed against the FccRIII/II
CD16/CD32 (0.5 ng mAb/106 cells). Cells were washed and
incubated with 1 ng/106 cells of the relevant mAb for 20 min at
4uC and washed again twice. In some experiments, cells were
subsequently incubated with 1 ng/106 cells of the second-step
reagent for 20 min at 4uC. The following antibodies were used:
APC-conjugated mAb binding CD4 GK1.5 (cat. no. 17-0041-83;
eBioscience, Frankfurt, Germany), CXCR3 CXCR3-173 (cat.
no. 17-1831-80; eBioscience) and CCR7 4B12 (cat. no.
FAB3477A; R&D systems); FITC-conjugated mAb binding CD4
GK1.5 (cat. no. 11-0041-86; eBioscience) and CD44 IM7 (cat.
no. 553133; BD Biosciences); PE-conjugated mAb binding CD103
M290 (cat. no. 557495; BD Bioscience) and a4b7 DATK32 (cat.
no. 553811; BD Bioscience); biotin-conjugated mAb binding
CD62L MEL-14 (cat.no. 13-062-85; eBioscience) and CCR9
eBioCW1.2 (cat. no. 13-1991-81; eBioscience). As a second-step
reagent PerCP-Cy5.5 was used.
Intracellular Foxp3 Staining
Cells were isolated, washed with PBS supplemented with 0.3%
BSA and 0.1% sodium azide and stained extracellularly with
FITC-conjugated anti-CD4 mAb binding CD4 GK1.5 (cat.
no. 11-0041-86; eBioscience). Surface-stained cells were than
pelleted and resuspended in 200 ml of Fixation/Permeabilization
buffer (cat. no. 00-5123-43; eBioscience). After overnight incuba-
tion at 4uC in the dark, cells were washed two times with
16Permeabilization buffer (cat. no. 00-8333-56; eBioscience) and
incubated for 15 min, 4uC with mAb 2.4G2 directed against the
FccRIII/II CD16/CD32 (0.5 ng mAb/106 cells) for preventing
non-specific binding of the Abs. Cell were pelleted and after
discarding the supernatant incubated for 30 min at 4uC, dark with
0.5 ng/106 cells of the PE-conjugated anti–Foxp3 FJK-16s (cat.
no. 12-5773-80; eBioscience) mAb diluted in 16Permeabilization
buffer. Stained cells were washed once with 16Permeabilization
buffer, once with PBS supplemented with 0.3% BSA and 0.1%
sodium azide, resuspended in PBS supplemented with 0.3% BSA
and 0.1% sodium azide and analyzed on FCM.
Cytokine Detection by ELISA
The concentration of IL-17 in the blood serums was measured
by a conventional double-sandwich ELISA. Capture mAb TC11-
18H10 (cat. no. 555068) and detection biotinylated mAb TC11-
8H4.1 (cat. no. 555067) were purchased from BD Bioscience.
Extinction was measured at 450 nm on a TECAN microplate-
ELISA reader using EasyWin software (both from Tecan, Wetzlar,
Germany).
Chemokine and Cytokine Expression Analyses by qRT-
PCR
RNA was prepared from approximately 30 mg of frozen tissue
samples (MLN, small intestinal or colon tissue) or from 107 fresh
spleen cells (sorted by MACS for CD4+ and CD42 fraction) using
the RNAeasy mini kit (cat. no. 74904; Qiagen, Hilden, Germany).
Contaminating genomic DNA was eliminated from samples by
treatment with RNAse – free DNAse I (cat. no. 1010395; Qiagen).
A total of 2 mg of RNA isolated from tissues or 200 ng of RNA
isolated from cells was reverse transcribed with SuperScript II
Reverse Transcriptase (cat. no. 18064-014; Invitrogen) using
random primers (cat. no. 48190-011; Invitrogen) according to
the manufacturer instructions. SYBR Green qPCR Master mix
(cat. no. PA-012-12; SABiosciences, Qiagen) was used for
amplification and detection. Real-time PCR reactions were
performed using the 7500 Fast Real-Time PCR System (Applied
Biosystems, Darmstadt, Germany) and the following conditions:
50uC 2 min, repeat 1; 95uC 10 min, repeat 1; 95uC 15 sec, 60uC
1 min, repeats 40; 95uC 15 sec, 60uC 1 min, 95uC 15 sec, 60uC
15 sec, repeat 1. b-actin PCR signals were used to equalize cDNA
amounts between preparations. Following primers from SA-
Bioscience, Qiagen group were used: b-actin (cat. no.
PPM02945A), IFN-c (cat. no. PPM03121A), CXCL-10 (cat. no.
PPM02978D), CCL-1 (cat. no. PPM03138B), CCL-19 (cat. no.
PPM03157B), CCL-5 (cat. no. PPM02960F) and CCL-8 (cat. no.
PPM03165A). Expected products length was: for b-actin 154 bp,
for IFN-c 95 bp, CXCL-10 106 bp, CCL-1 92 bp, CCL-19 100 bp,
CCL-5 96 bp and CCL-8 168 bp.
Statistics
We performed Mann-Whitney test for assessing the difference of
two samples and one-sample t-tests for testing the deviation from
the theoretical mean (GraphPad Prism V4). The difference
between data sets of three and more groups was analyzed with
Kruskal-Wallis test and Mann-Whitney as post-hoc test (Graph-
Pad Prism V4). P#0.05 was considered statistically significant.
Results
Increased Expression of Chemokines in the Absence of
CD69
To identify transcripts differentially regulated by the CD69
activation marker in CD4 T lymphocytes we carried out
microarray analysis. We compared gene expression profiles of 3
groups: anti-CD3/CD28 activated B6 CD4 T cells; anti-CD3/
CD28 activated CD692/2 CD4 T cells and anti-CD3/CD28
activated B6 CD4 T cells on which surface CD69 molecule was
activated by cross-linking. CD69 regulated the expression of
chemokines as we observed the significant differences between our
groups. Activation of CD69 significantly reduced the expression of
XCL-1, CCL-4, CCL-1, CCL-9, CCL-3, CXCL-9 and CXCL-10
chemokine and CCR-8, CCR-4, CCR-5 chemokine receptor
transcripts in B6 CD4 T cells as compared to CD692/2 CD4 T
cells (Table 1). The expression of most chemokines was reduced
in CD69-activated B6 CD4 T cells when compared to B6 CD4 T
cells, but increased in CD692/2 as compared to B6 CD4 T cells
(Table S1 and Table S2).
To analyse if CD69 affects the expression of chemokines in vivo,
we conducted qRT-PCR analyses. In absence of CD69 an
increased expression of CCL-1, CXCL-10 and CCL-19 genes was
observed in mesenteric lymph nodes (MLN), small intestinal (si)
and colonic (co) tissues (Fig. 1A–C). To identify the cell source of
increased chemokine production, RNA was isolated from CD4+
and CD42 cells of B6 and CD692/2 mice, reverse transcribed to
cDNA and analysed by qRT-PCR. Confirming the micro-array
data, increased expression of CCL-1 and CXCL-10 was found in
CD692/2 CD4+ T cells (Fig. 1D,E). CD692/2 CD42 cells
showed increased expression of CCL-1 and CCL-19 but not of
CXCL-10 gene (Fig. 1D–F). However, no significant difference in
expression of CCL-5 and CCL-8 was observed (Fig. S1). These
data indicated that CD69 negatively regulates the expression of
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chemokines which protein products are involved in the migration
of naive, activated and memory lymphocytes, in both CD4+ and
CD42 cell populations.
CD69 Regulates the Migration of CD4 T cells Toward the
Chemokine Gradient in vitro
As CD69 regulated the expression of chemokines, we
investigated if CD69-deficiency affects the response of CD4 T
cells toward the chemokine gradient in vitro. In this assay we
used the transwell system with the polycarbonate membrane
that prevents the diffusion of medium, but allows the migration
of CD4 T cells in between the chambers. The lower chamber
contained pure medium or the medium with titrated concen-
trations of chemokine. Upper chamber was filled with medium
containing B6 or CD692/2 spleen CD4 T cells. After 1 h
incubation at 37uC, 5% CO2 the number of cells that migrated
to the lower chamber was counted by FCM. There was no
difference in the number of B6 and CD692/2 CD4 T cells
migrating to the medium alone (Fig. 2A). When CCL-1,
CXCL-10 or CCL-5 were added to the medium significantly
increased numbers of CD69-deficient as compared to B6 CD4
T cells were migrating toward the chemokine gradient for most
of the chemokine concentrations tested (Fig. 2B–D). Chemo-
tactic index represents the number of cells counted in the
medium containing the chemokine normalized to the mean cell
number counted in the pure medium and it was calculated for
every chemokine concentration used. CD692/2 CD4 T cells
showed significantly increased chemotactic index for CCL-1,
CXCL-10 and CCL-5 (Fig. 2E–G). Increased migration of
CD69-deficient CD4 T cells toward CCL-1 and CCL-5
correlated with increased expression of the respective chemokine
receptors for these chemokines, CCR-8 and CCR4/CCR5,
respectively (Table S2). Significant differences between B6 and
CD692/2 CD4 T cells were not observed when the chemokine
CCL-4 (another CCR4/CCR5 ligand) was used in our
experiments (Fig. 2E,I). The expression of the CXCL-10
receptor, CXCR-3, by CD692/2 CD4 T cells was not
increased (Fig. S2). Thus, CD69-deficiency increases the
chemokine-dependent migratory potential of CD4 T cells
toward some, but not all chemokines.
CD69 Regulates the Homing of CD4 T cells to the
Intestinal Tissues in vivo
To compare the migration pattern of B6 and CD692/2 CD4 T
cells, we performed an in vivo competitive homing assay. Equal
numbers of red DsRed+ B6 and green CFSE+ CD692/2 CD4 T
cells were transferred into the B6 mice. For easier detection of
transferred lymphocytes the donor cells were expressing the
common leukocyte antigen isotype CD45.2 and the host cells the
isotype CD45.1. Lymphocytes were isolated 18 or 72 h post-
transfer from the blood and intestinal tissues (MLN, siLP and cLP)
of the hosts and the numbers of transferred DsRed+ B6 or CFSE+
CD692/2 cells among the CD4+ CD45.2+ cell population were
determined by FCM. 18 h after transfer the number of B6 and
CD69-deficient CD4 T cells in the blood was the same while in
MLN, siLP and cLP the number of CD692/2 CD4 T cells was
significantly increased (Fig. 3A). These results are confirmed for
small intestinal and colonic tissue by ex vivo confocal imaging as we
observed higher number of green CD692/2 than red B6 CD4 T
cells in both tissue samples (Fig. 3C). 72 h after the cell transfer
significantly increased numbers of CD69-deficient cells were found
in the intestinal tissues but also in blood (Fig. 3D). Possible
retention of B6 CD4 T cells in some of the organs non-analysed
here could contribute to the observed results. To eliminate this
effect of tissue cell retention, we expressed the results of this assay
also as homing index (HI). HI for intestinal tissues were calculated
as the ratio of CD692/2 to the B6 CD4 T cell number recovered
from the hosts normalized to the IR of the injected cells and also
normalized to the blood HI. This analyzes showed that 18 h post-
transfer CD692/2 CD4 T cells have an increased potential to
migrate to the siLP and cLP, but not to MLN (Fig. 3B). 72 h after
the cell transfer CD69-deficient CD4 T cells had a reduced
potential to migrate to the MLN and same potential to migrate to
siLP and cLP when compared to B6 CD4 T cells (Fig. 3E). This
assay showed that CD69-deficient CD4 T cells migrate more
efficiently than B6 cells to the intestinal tissues at early, but not late
time point.
Cells on OT-II background showed slightly different migratory
behaviour in this assay. 72 h after the DsRed OT-II/CFSE+ OT-
II6CD692/2 CD4 T cells were transferred into hosts, no
difference in cell number could be observed in any tissue analysed
(Fig. S3). When transferred mice were fed the specific antigen,
OVA, increased number of CD69-deficeint OT-II CD4 T cells
was found in siLP (Fig. S3). This means that homing of OT-II
Table 1. Expression of selected chemokine-related genes differentially expressed in CD69-activated B6 compared to CD692/2 CD4
T cells analyzed by microarray.
Gene symbol Description Fold-change (log2) FDR
Xcl1 chemokine (C motif) ligand 1 23.09 5.48e-14
Ccl4 chemokine (C-C motif) ligand 4 21.45 1.08e-05
Ccl1 chemokine (C-C motif) ligand 1 21.00 1.49e-05
Ccl9 chemokine (C-C motif) ligand 9 21.09 0.00016
Ccl3 chemokine (C-C motif) ligand 3 21.45 5.48e-14
Cxcl9 chemokine (C-X-C motif) ligand 9 21.56 5.48e-14
Cxcl10 chemokine (C-X-C motif) ligand 10 21.75 5.48e-14
Ccr8 chemokine (C-C motif) receptor 8 21.48 5.48e-14
Ccr4 chemokine (C-C motif) receptor 4 21.07 4.48e-11
Ccr5 chemokine (C-C motif) receptor 5 21.08 1.8e-06
Genes with a fold change (log2)$1.00 and false discovery rate (FDR)#0.05 were considered as differentially expressed.
doi:10.1371/journal.pone.0065413.t001
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CD4 T cells to intestinal tissues depends not only on CD69, but
also on presence of the antigen.
CD69 Regulates Naı¨ve/memory Cell Ratio in CD4 T cell
Population
Different migration patterns of B6 and CD692/2 CD4 T
cells observed in vivo could be the consequence of different
expression of naı¨ve and memory surface cell markers. There-
fore, we investigated by FCM the expression of these markers
on B6 and CD692/2 CD4 T cells. Absence of CD69
significantly reduced the expression of memory cell markers in
CD4 T cell population: CD44 in all tissues tested except of
blood and CD103 in spleen and siLP (Fig. 4A,B). On the other
hand, the expression of CD62L, marker of naı¨ve cells and the
chemotactic receptor that regulates the migration to lymph
nodes and intestine, was increased in spleen, MLN and siLP of
CD692/2 mice (Fig. 4C). The expression of another naı¨ve cell
marker, CCR-7, did not significantly differ between B6 and
CD692/2 CD4 T cells (Fig. 4D). The expression of CCR-9,
an intestine homing marker, was increased only in the spleen of
CD69-deficient mice (Fig. 4E), while no differences were
observed in the expression of a4b7 (Fig. 4F). These data
indicated that the expression of main intestine homing markers
is generally not affected by CD69. However, CD69 regulates
naı¨ve/memory cell ratio with CD692/2 mice having a reduced
fraction of memory CD44+ and CD103+ CD4 T cells and
increased fraction of naı¨ve CD62L+ CD4 T cells.
Severe Colitis Induced in CD692/2 Mice after the DSS
Administration Depends on Increased Accumulation of
CD4 T cells in cLP Attracted by CCL-1, CXCL-10 and CCL-
19
Administration of 2% DSS in the drinking water induced severe
colitis in CD69-deficient mice as observed by the accelerated body
weight loss compared to the DSS treated B6 animals and non-
treated control group (Fig. 5A). Severity of intestinal inflammation
is evaluated by histopathological examination of the colon.
Average colitis score was significantly increased in the group of
DSS-treated CD692/2 mice when compared to the DSS-treated
B6 and non-treated control groups (Fig. 5B). Colonic tissue of the
control mice showed normal architecture and cellularity on the
histological slides, while after the DSS treatment in B6 animals the
Figure 1. Absence of CD69 leads to the increased expression of CCL-1, CXCL-10 and CCL-19. RNA was isolated from the frozen mesenteric
lymph nodes (MLN), small intestinal (si) and colonic (co) tissue samples or from sorted CD4+ and CD42 spleen cells of non-treated B6 or CD692/2
animals and reverse transcribed to complementary DNA. Relative expression of CCL-1 (A and D), CXCL-10 (B and E) and CCL-19 (C and F) genes
compared to b-actin gene is analyzed by qRT-PCR. Mean (6 SEM) for at least six mice per each strain is presented. *p#0.05; **p#0.005; ***p#0.0005;
N.S. – not significant.
doi:10.1371/journal.pone.0065413.g001
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signs of mild inflammation were observed (Fig. 5C). In CD692/2
mice a massive infiltration of inflammatory cells and the los of
tissue architecture confirmed the severity of the disease (Fig. 5C).
Relative quantification of gene expression by RT-PCR was
conducted using the RNA isolated from the frozen tissue sections
of proximal colon taken from DSS administrated B6 and CD692/
2 mice and non-treated control animals. These analyzes revealed
significant increase in the expression of CCL-1, CXCL-10 and CCL-
19 in the inflamed colon tissue of DSS-treated CD692/2 mice
when compared to the other experimental groups (Fig. 5D–F).
The treatment of DSS-induced colitis in CD692/2 mice with the
mixture of Abs that neutralize CCL-1, CXCL-10 and CCL-19 did
not affect the accelerated body weight loss (Fig. 5A), but it
reduced significantly the histopathological severity of the disease
(Fig. 5B). CD69-deficient animals treated with neutralizing Abs
showed the signs of mild colitis, with normal number of goblet
cells, slightly elongated colonic crypts and few infiltrating
inflammatory cells (Fig. 5C). Severe colonic inflammation with
infiltration of high number of inflammatory cells into the colonic
wall observed in CD692/2 mice after DSS administration could
be caused by the increased expression of pro-inflammatory
chemokine ligands.
High pro-inflammatory Cytokine Response and Early
Influx of CD4 T cells Devoid of Foxp3 Treg Cells into cLP
are Observed in DSS-treated CD692/2 Mice
To investigate the influence of the factors other than
chemokines in DSS colitis model, we analyzed expression/
production of pro-inflammatory cytokines as well. We saw that
DSS-administrated CD69-deficient mice have significantly in-
creased serum level of IL-17 as compared to the DSS-treated B6
and non-treated control group (Fig. 6A). Also, expression of the
gene encoding pro-inflammatory cytokine IFN-c was increased in
the colonic tissue of the CD692/2 animals treated with DSS
Figure 2. Increased in vitro functionality of CD4 T cell chemokine receptors for CCL-1, CXCL-10 and CCL-5 in the absence of CD69.
CD4 T cells were enriched from the spleen of B6 or CD692/2 mice and migration of these cells was analysed in vitro in transwell system. Medium
alone or containing indicated concentrations of CCL-1, CXCL-10, CCL-5 and CCL-4 were loaded in the lower chamber of the transwell system, while
CD4 T cells in the medium were loaded in the upper chamber. Cell number migrating from the upper chamber to the chemokine containing chamber
trough polycarbonate membrane after 1 h at 37uC, 5% CO2 was counted by flow cytometry. All the reactions were done in at least four repeats and
average cell number per chemokine concentration per cell type was calculated. Results are presented as the number of cells migrating to the wells
containing medium alone (A) or indicated concentration of CCL-1 (B), CXCL-10 (C), CCL-5 (D) or CCL-4 (E). Mean (6 SEM) for at least four repeats per
each chemokine concentration and cell type is presented. The lower graph set represents chemotactic indexes of B6 and CD692/2 CD4 T cells for
CCL-1 (F), CXCL-10 (G), CCL-5 (H) and CCL-4 (I). The chemotactic index was calculated as: the number of cells migrating to the media with chemokine
divided by the average number of cells migrating to the media alone. *p#0.05.
doi:10.1371/journal.pone.0065413.g002
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(Fig. 6B). Furthermore, three days after the DSS administration
CD692/2 mice had reduced number of CD4 T cells in MLN and
increased number of these cells in cLP when compared to B6
animals (Fig. 6C). Further analyses of these CD4 T cells showed
that 3 days after the DSS administration CD4 T cell population in
cLP of CD69-deficient mice contained significantly reduced
fraction of Foxp3-expressing Treg cells compared to B6 mice,
while in blood and MLN there was no difference (Fig. 6D,E).
This early influx of CD4 T cells devoid of Treg cells together with
the increased levels of pro-inflammatory cytokines contribute to
the severe pathology observed in the colon of CD692/2 mice
treated with DSS.
OT-II6CD692/2 CD4 T cells Accumulate in cLP During
Transfer Colitis Model
Antigen-specific transfer colitis model was established to study
the inflammatory response of CD4 T cells in the presence or
absence of specific antigen in intestinal lumen. CD45RBhigh CD4
T cells were sorted from the splenocytes of OT-II or OT-
II6CD692/2 mice and adoptively transferred into the RAG2/2
hosts. After the transfer hosts were fed or not every second day
with 1 mg OVA protein. Both groups fed with OVA developed
colitis, but the disease was more severe in the hosts transferred
with OT-II6CD692/2 cells and fed with OVA as showed by
accelerated body weight loss compared to all the other groups
(Fig. 7A) and by severe histopathology in colon (Fig. 7B,C). The
hosts transferred with OT-II or OT-II6CD692/2 CD45RBhigh
CD4 T cells that were not fed with OVA, normally gain body
Figure 3. Increased migratory potential of CD69-deficient CD4 T cells to the mucosal intestinal tissues in vivo. CD4 T cells were
enriched from the spleen of red fluorescent DsRed or CD692/2 animals, both on the CD45.2+ B6 background. CD69-deficient CD4 T cells were
labelled with green fluorescent CFSE. These cells were mixed in the approximate ratio 1:1 and injected i.v. into CD45.1+ B6 mice. 18 or 72 h later cells
were isolated from blood, mesenteric lymph nodes (MLN), small intestinal lamina propria (siLP) and colonic lamina propria (cLP) of the hosts and
analyzed for the surface expression of CD4, CD45.2, DsRed and CFSE by multicolour flow cytometry (FCM). Numbers of DsRed and CFSE expressing
CD45.2+ CD4+ cells recovered 18 h (A) or 72 h (D) after the transfer from the host tissues were determined with FCM and presented as mean (6 SEM)
total number of recovered cells per tissue for four mice analyzed. N.S. – not statistically significant; *p#0.05. Homing index (HI) for every tissue 18 h
(B) or 72 h (E) post-injection is calculated as: HI = number of CD4+CD45.2+CFSE+ cells/number of CD4+CD45.2+DsRed+ cells : IR (where IR is input ratio
calculated before the injection as: IR = number of CD4+CD45.2+CFSE+ cells/number of CD4+CD45.2+DsRed+ cells). This value was normalized to the HI
in the blood, so the potential retention of the injected cells in some of the periphery organs is eliminated. Mean (6 SEM) of blood-normalized HI per
tissue for four mice is presented. The deviation from the theoretical mean (TM= 1) was assessed (*p#0.05). C. 18 h after the cell transfer sections of
small intestine and colon of the host were stained with Alexa Fluor 350-conjugated wheat germ agglutinin (blue) analyzed for the number of green
(CFSE+ CD692/2) and red (DsRed+ B6) CD4 T cells by confocal microscope (original magnification640).
doi:10.1371/journal.pone.0065413.g003
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weight as the control group (Fig. 7A), although OT-II6CD692/2
cell-transferred mice showed more severe histopathology in
colonic tissue (Fig. 7B,C). Total number of OT-II CD4 T cells
in cLP of the hosts was significantly increased compared to the
control in the presence of antigen (Fig. 7D). The number of cLP
OT-II6CD692/2 CD4 T cells was increased significantly in both
groups fed or not fed with OVA when compared to the control
group (Fig. 7D). These data indicated that the accumulation of
OT-II CD4 T cells in cLP is CD69-dependent in antigen-specific
transfer model of colitis.
Discussion
The data presented in this study indicated that the activation
marker CD69 is involved in the regulation of chemokine
expression. CD69-deficient mice showed increased transcript
levels of some chemokine genes, such as CCL-1, CXCL-10 and
CCL-19 in steady-state conditions and after colitis induction. We
saw that CD69 regulates the expression of chemokine genes in
both CD4+ and CD42 cells. The portion of chemokines secreted
by CD4+ T cells is considered to be minor, but it can still be
important for the functions of immune cells [41,42]. In vitro
chemotactic assay showed that CD692/2 CD4 T cells respond
more efficiently to the chemokine stimuli compared to B6 CD4 T
cells. This could be the result of increased chemokine receptor
Figure 4. B6 and CD692/2 CD4 T cells differ in the expression of naı¨ve and memory surface cell markers. Cells were isolated from the
spleen (spl), mesenteric lymph nodes (MLN), small intestinal lamina propria (siLP), colonic lamina propria (cLP) and blood (bld) of non-treated B6 and
CD692/2 mice and analyzed by flow cytometry. The surface expression of CD44 (A), CD103 (B), CD62L (C), CCR-7 (D), CCR-9 (E) and a4b7 integrin (F)
by CD4 T cells were analysed. Graphs represent mean (6 SEM) of CD4 T cell fraction expressing the indicated molecule for four mice per each strain
per tissue. Black bars represent data for B6 and white bars for CD692/2 cells. *p#0.05.
doi:10.1371/journal.pone.0065413.g004
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expression or, most probably, increased receptor affinity in CD69-
deficient CD4 T cells. Hence, not only that CD69 regulates the
chemokines expression, but it also modulates the ability of CD4 T
cells to respond to stimulation with respective chemokine.
However, the expression of some chemokines was not affected
by CD69 and also CD692/2 CD4 T cells responded the same as
B6 CD4 T cells to the in vitro stimulation by CCL-4. The
mechanisms for this selectivity in CD69-dependent chemokine
responses are not known. Identification of intracellular pathways
downstream of CD69 would help resolving this question.
In in vivo competitive homing assay, CD69-deficient CD4 T
cells migrated more efficiently to the intestine at early time points
Figure 5. Increased susceptibility of CD692/2mice to DSS induced colitis is partially due to increased chemokine-dependent CD4 T
cell migration to cLP. B6 or CD692/2 mice are administrated 2% dextrane sodium sulphate (DSS) in the drinking water for 5 days and then
provided with normal sterile water. One group of DSS-administrated CD692/2 mice were treated with the mixture of CCL-1, CXCL-10 and CCL-19
blocking Abs by i.p. injection at days 0, 2, 4 and 6 (CD692/2+Ch-block group). The control group represents non-treated B6 animals. A.Mean (6 SEM)
of body weight loss (%) of at least 5 mice per group is shown. B. Colitis scores of the histological colon sections of DSS treated B6 and CD692/2mice,
control and CD692/2+Ch-block groups. Mean (6 SEM) for at least five mice per group are presented. C. Histopathological colon tissue samples taken
from control B6 mice, DSS treated B6 or CD692/2 animals and CD692/2+Ch-block group were embedded in paraffin, sectioned on a microtome,
mounted on slides, and stained with H&E. Representative images of one individual mouse per group (from at least five mice per group analyzed) are
shown (original magnification620). RNA was isolated from the frozen colon tissue samples of control B6 animals and DSS treated B6 or CD692/2mice
and reverse transcribed to complementary DNA. Relative expression of CCL-1 (D), CXCL-10 (E) and CCL-19 (F) genes compared to b-actin gene is
measured by qRT-PCR. Mean (6 SEM) for at least five mice per group are presented. N.S. – not statistically significant; *p#0.05; **p#0.005.
doi:10.1371/journal.pone.0065413.g005
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after adoptive cell transfer into hosts. This could be explained by
very efficient response to chemokine attraction or by increased
expression of CCR-9 and CD62L by splenic CD692/2 CD4 T
cells used in this assay. CCR-9 is a well defined intestinal homing
receptor [43,44] while CD62L regulates lymphocyte homing to
peripheral lymph nodes [45] and binds also to MadCAM-1
expressed in the intestine [46]; possible these molecules may be
involved in the results we observed in in vivo competitive homing
assays. This assay also showed that at later time points CD692/2
cells have reduced homing index to MLN and that they are
abound in the blood. This could be the result of their inability to
down-modulate S1P1 receptor and stay in the lymphoid organs.
Feeding the hosts with specific antigen after the cell transfer
resulted in the increased migration of CD692/2 CD4 T cells to
the siLP, the place where antigen was located. Therefore, the
presence of specific antigen is also important in CD4 T cell
homing to the intestine. Possible differences in cell proliferation
and retention, especially at later time points, and also possible
effect of different fluorescent markers (DsRed and CFSE) on cell
migration cannot be excluded in this assay.
Recently CD69 has been recognized as a marker of tissue
resident memory T cell population [47,48,49,50]. In this study we
showed for the first time that CD692/2 mice have decreased
fraction of CD44+ and CD103+ memory CD4 T cells in peripheral
tissues. These data confirmed that CD69 is important for the
development of peripheral memory cell pool. Furthermore,
disturbed naı¨ve/memory cell ratios can change the migratory
pattern of CD4 T cells and can be one of the factors contributing
to the effects observed in this study.
Using two different colitis models we showed that CD692/2
CD4 T cells accumulate preferably in the cLP under the
inflammatory conditions. In DSS colitis model this was at least
Figure 6. Severe colitis in DSS treated CD692/2 mice is associated with increased pro-inflammatory response and early influx of
CD4 T cells devoid of Foxp3 Treg cell into the colon. A. IL-17 concentration was determined by ELISA in the sera of control B6 mice and DSS
treated B6 and CD692/2 mice 7 days after the DSS administration. Mean (6 SEM) of at least five mice per group is presented. B. RNA was isolated
from frozen colon tissue samples of B6 and CD692/2 mice treated with DSS, seven days after the DSS administration, or the control B6 mice and
reverse transcribed to cDNA. Relative expression of IFN-c gene was measured by qRT-PCR and presented as mean 6 SEM of at least five mice per
group. C. Mean (6 SEM) total number of CD4+ T cells in blood, mesenteric lymph nodes (MLN) and colonic lamina propria (cLP) of 3 days DSS treated
B6 and CD692/2 mice are shown. At least five mice per each strain were analysed. D. The expression of Foxp3 by CD4 T cells from blood, MLN and
cLP of B6 and CD692/2 mice treated with DSS for 3 days was analysed by flow cytometry. Data from an individual, representative mouse (out of at
least 5 mice per group analysed) are shown. Numbers indicate the percentage of CD4 T cells that express the transcriptional factor Foxp3. E. Mean (6
SEM) total number of CD4+ Foxp3+ T cells in blood, MLN and cLP of 3 days DSS treated B6 and CD692/2 mice are shown. At least five mice per each
strain were analyzed. N.S. – not statistically significant; *p#0.05; **p#0.005.
doi:10.1371/journal.pone.0065413.g006
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Figure 7. CD69-defficient OT-II CD4 T cells accumulate in cLP of RAG2/2 hosts during an antigen specific transfer colitis. Antigen
specific colitis was induced by the transfer of CD45RBhigh CD4 T cells, isolated from the spleen of OT-II or OT-II6CD692/2 mice, into the RAG2/2
animals. Cell transfer was in some groups followed by the intragastrical feeding of the hosts with 1 mg OVA protein every second day. A. Mean (6
SEM) of body weight loss (%) of at least five mice per group is shown for non-treated RAG2/2 animals (control group), hosts transferred with OT-II or
OT-II6CD692/2 cells and not fed with OVA (OT-II and OT-II6CD692/2 groups) and host transferred with OT-II or OT-II6CD692/2 cells and fed with
OVA (OT-II+OVA and OT-II6CD692/2+OVA groups). B. Histopathological colon tissue samples taken from the control, OT-II, OT-II6CD692/2, OT-
II+OVA and OT-II6CD692/2+OVA groups were embedded in paraffin, sectioned on a microtome, mounted on slides, and stained with H&E.
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partially dependent on the increased expression levels of the
chemokines CCL-1, CXCL-10 and CCL-19 in the colon of CD69-
deficient animals, as neutralization of these three chemokines
significantly improved the histopathological picture in colon.
However, the chemokine-blocking treatment did not affect the
body weight loss in DSS colitis model, indicating that other factors
such as increased production of pro-inflammatory cytokines and
decreased cLP Foxp3 Treg cell fraction play an important role in
the disease development. In antigen specific colitis model OT-
II6CD692/2 CD4 T cells accumulated in cLP with or without
antigen presence showing that this effect is only CD69-dependend.
However, it is not clear weather this accumulation is a result of cell
migration or proliferation, as the effect of CD69 on cell
proliferation is not known.
Our study provides first evidence that CD69 does not regulate
the lymphocyte migration only by influencing S1P1 expression, but
also by regulating the expression of chemokines and naı¨ve/
memory T cell markers. We also showed that absence of CD69
leads to the accumulation of CD4 T cells in the intestinal mucosa.
We hypothesize that in physiological conditions the up-regulation
of CD69 on activated CD4 T cells in the intestine acts as a
negative feedback mechanism to prevent the excessive inflamma-
tion by reducing the amounts of produced pro-inflammatory
chemokines and cytokines and by increasing the fraction of Foxp3
Treg cells and memory cells. Our study indicated that CD69
regulates the immune system in very complex ways and showed
the need for further studies that will determine the mechanisms by
which CD69 regulates the functions of lymphocytes.
Supporting Information
Figure S1 Absence of CD69 does not affect the expres-
sion of CCL-5 and CCL-8. RNA was isolated from the frozen
mesenteric lymph nodes (MLN), small intestinal (si) and colonic
(co) tissue samples or from sorted CD4+ and CD42 spleen cells of
non-treated B6 or CD692/2 animals and reverse transcribed to
complementary DNA. Relative expression of CCL-5 (A and C) and
CCL-8 (B and D) as compared to b-actin gene is analysed by qRT-
PCR. Mean (6 SEM) for at least six mice per each strain is
presented. N.S. – not significant
(TIF)
Figure S2 B6 and CD692/2 mice do not differ in the
surface expression of CXCR-3 receptor by CD4 T cells.
Cells were isolated from the spleen (spl), mesenteric lymph nodes
(MLN), small intestinal lamina propria (siLP), colonic lamina
propria (cLP) and blood (bld) of non-treated B6 and CD692/2
mice and analyzed by flow cytometry. Graph represents mean (6
SEM) of CD4 T cell fraction expressing CXCR-3 for four mice
per each strain per tissue. *p#0.05
(TIF)
Figure S3 OT-II6CD692/2 CD4 T cells are homing in
the higher numbers to the small intestine in the
presence of antigen. CD4 T cells were enriched from the
spleen of transgenic OT-II6DsRed or OT-II6CD692/2 mice
(both on Vb5+ background). CD69-deficient cells were labelled
with CSFE. Red fluorescent OT-II6DsRed and green fluorescent
CFSE+ OT-II6CD692/2 CD4 T cells were mixed in the ratio 1:1
and transferred to the B6 hosts. Host were fed or not
intragastrically with 1 mg ovalbumin protein daily. Three days
after, the cells were obtained from the blood, mesenteric lymph
nodes (MLN), small intestinal lamina propria (siLP) and colonic
lamina propria (cLP) of the hosts. A. The number of DsRed+ OT-
II and CFSE+ OT-II6CD692/2 cells among CD4+Vb5+ cell
population was determined in the tissues of the hosts by flow
cytometry and presented as mean (6 SEM) total number of
recovered cells per tissue for five mice analyzed. N.S. – not
statistically significant; *p#0.05. B. Homing index (HI) for every
tissue is calculated as: HI= number of CD4+ Vb5+CFSE+ cells/
number of CD4+ Vb5+DsRed+ cells: IR (where IR is input ratio
calculated before the injection as: IR=number of CD4+
Vb5+CFSE+ cells/number of CD4+ Vb5+DsRed+ cells). HI for
intestinal tissues was normalized to the HI in the blood to
eliminate the potential retention of the injected cells in some of the
periphery organs. Mean (6 SEM) of blood-normalized HI per
tissue for five mice is presented. The deviation from the theoretical
mean (TM=1) is assessed (*p#0.05).
(TIF)
Table S1 Expression of selected chemokine-related
genes differentially expressed in CD69-activated com-
pared to B6 CD4 T cells analyzed by microarray.
(DOCX)
Table S2 Expression of selected chemokine-related
genes differentially expressed in CD692/2 compared to
B6 CD4 T cells analyzed by microarray.
(DOCX)
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